NL7118224A - Salicylate carbonate compsns - for sustai ined - release of acetyl salicylic acid in body derivs - Google Patents

Salicylate carbonate compsns - for sustai ined - release of acetyl salicylic acid in body derivs

Info

Publication number
NL7118224A
NL7118224A NL7118224A NL7118224A NL7118224A NL 7118224 A NL7118224 A NL 7118224A NL 7118224 A NL7118224 A NL 7118224A NL 7118224 A NL7118224 A NL 7118224A NL 7118224 A NL7118224 A NL 7118224A
Authority
NL
Netherlands
Prior art keywords
compsns
sustai
derivs
ined
release
Prior art date
Application number
NL7118224A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NL7118224A priority Critical patent/NL7118224A/en
Publication of NL7118224A publication Critical patent/NL7118224A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compsns. contg. as active ingredients cpds. (I) (where R is 2-30C opt. unsatd. aliphatic or alicyclic, alcohol or polyhydroxy radical) capable of sustaining an effective level in plasma of salicylate.
NL7118224A 1971-12-31 1971-12-31 Salicylate carbonate compsns - for sustai ined - release of acetyl salicylic acid in body derivs NL7118224A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL7118224A NL7118224A (en) 1971-12-31 1971-12-31 Salicylate carbonate compsns - for sustai ined - release of acetyl salicylic acid in body derivs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7118224A NL7118224A (en) 1971-12-31 1971-12-31 Salicylate carbonate compsns - for sustai ined - release of acetyl salicylic acid in body derivs

Publications (1)

Publication Number Publication Date
NL7118224A true NL7118224A (en) 1973-07-03

Family

ID=19814833

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7118224A NL7118224A (en) 1971-12-31 1971-12-31 Salicylate carbonate compsns - for sustai ined - release of acetyl salicylic acid in body derivs

Country Status (1)

Country Link
NL (1) NL7118224A (en)

Similar Documents

Publication Publication Date Title
CA1010055A (en) PREPARATION OF OPTICALLY ACTIVE ESTERS OF .alpha.-AMINO ACIDS
CA990871A (en) Treatment of water or aqueous systems
CA927928A (en) Treatment of surfaces with low-pressure plasmas
CA973660A (en) Treatment of cellulosic matter with active nitrogen
FI54796C (en) PROCEDURE FOR THERAPEUTIC TREATMENT OF THE THERAPEUTIC ACID ESTRAR AV ALPHA-AMINOMETHYL-3- (HYDROXI ELLER HYDROXIMETYL) -4-HYDROXIBENYL ALCOHOL
FR2165760A1 (en) Salicylate carbonate compsns - for sustai ined - release of acetyl salicylic acid in body derivs
NL7118224A (en) Salicylate carbonate compsns - for sustai ined - release of acetyl salicylic acid in body derivs
BE777569A (en) Salicylate carbonate compsns - for sustai ined - release of acetyl salicylic acid in body derivs
SE377991B (en) PROCEDURE FOR STABILIZATION OF VITAMIN C IN BEVERAGES AND CONCENTRATED THEREOF
SE401090B (en) USE OF CERTAIN ESTERS OF PHOSPHORIC ACIDITY AS ACTIVE SUBSTANCES IN DISINFECTANTS
FR2107980A1 (en) Beta-amino-penicillins - antibacterials which give high blood levels on oral administration
ES411617A1 (en) Cyanophenyl esters of oxime-o-carbonic acid
FR2077790A1 (en) Anti-rheumatism medicament - contg butylsalicylamine and ethyl salicylamide
FR1281M (en) New drug consisting of α (3-acetylamino-2,4,6-tri-iodo-phenoxy) -caproic acid, or its salts.
FR2054067A5 (en) Glycerol production from allyl alcohol - and percarboxylic acids
FR2172549A5 (en) Ketal inters - for preparing d-homo-steroids with hypolipaemic or hormonal activity
CA970088A (en) Stable solutions of polyglutamic acid derivatives
IL36432A0 (en) Process for the manufacture of optically active bicycloalkane derivatives
CA859699A (en) Medicine for treatment of infections
CA838661A (en) Therapeutic compositions containing saturated solution of salicylic acid in propylene glycol
BE802078A (en) Oxytocin and desamino-oxytocin compsns - for treatment of impotence in males
FR2088137A1 (en) Sorbitoglycerides - with cholagoguic activity prepared by transesteri of maize oil
CA839741A (en) Preparation of optically active (-)-zearalenone
FR2109183A5 (en) Sugar coating for tablets etc
AU465117B2 (en) Cholerteically active esters and salts of bile acids